Peptipedia
ImmuneNot FDA ApprovedClinical Trials

Thymogen

Also known as EW Dipeptide, Glu-Trp, L-Glutamyl-L-Tryptophan, Oglufanide

A synthetic dipeptide (Glu-Trp) bioregulator derived from Thymalin, representing one of Professor Khavinson's key immunomodulatory compounds.

Approved in Russia for clinical immunomodulation use
CompareFind Vendors

Regulatory Pathway

Preclinical
Phase I
Phase II
Phase III
Phase IV
Approved

Dosing Protocol

Typical Dose

1-2 capsules (10-20 mg) daily

Frequency

1-2x daily, before meals

Duration

30-day courses with 2-3 month breaks

Community-reported dosing. Individual results vary. Not a medical recommendation.
Typical community protocol: 1-2 capsules (10-20 mg) daily via Oral capsules or nasal spray, 1-2x daily, before meals. Dose range: 10-20 mg daily. Duration: 30-day courses with 2-3 month breaks.

Timing & Administration

Administer via Oral capsules or nasal spray. Frequency: 1-2x daily, before meals.

Mechanism of Action

Stimulates cellular factors of immunogenesis, promotes proliferation and differentiation of T-lymphocyte precursors, and normalizes helper/suppressor T-cell ratios while modulating immune maturation.

Research Summary

Evidence level: clinical trials. Clinical status: Approved in Russia for clinical immunomodulation use.

Side Effects & Safety

Important Warnings

  • No significant side effects reported in clinical use
Generally well-tolerated
rare allergic reactions

References

No references available.

Related Peptides

Browse all →
LL-37Immune

A naturally occurring antimicrobial peptide and the only human cathelicidin. Part of the innate immune system with broad-spectrum antimicrobial activity.

View profile
Thymosin Alpha-1Immune

A naturally occurring thymic peptide that enhances immune function.

View profile
KPVImmune

A tripeptide derived from alpha-melanocyte stimulating hormone (α-MSH). Known for potent anti-inflammatory effects, particularly in the gut.

View profile